There is no Press for this Ticker
BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack.

Related Companies

TickerCompanyChg %Mkt Cap
BCDAWBioCardia, Inc. - Warrant-8.35%

BioCardia, Inc. - Warrant Frequently Asked Questions

Q

How do I buy BioCardia, Inc. - Warrant (BCDAW) stock?

A

You can purchase shares of BioCardia, Inc. - Warrant (NASDAQ: BCDAW) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BioCardia, Inc. - Warrant's (BCDAW) competitors?

A

There are no as such competitors for BioCardia, Inc. - Warrant.

Q

What is the target price for BioCardia, Inc. - Warrant (BCDAW) stock?

A

There is no analysis for BioCardia, Inc. - Warrant

Q

Current Stock Price for BioCardia, Inc. - Warrant (BCDAW)?

A

The stock price for BioCardia, Inc. - Warrant (NASDAQ: BCDAW) is $1.6039 last updated Thu Jul 22 2021 14:09:56 GMT+0000 (Coordinated Universal Time).

Q

Does BioCardia, Inc. - Warrant (BCDAW) pay a dividend?

A

There are no upcoming dividends for BioCardia, Inc. - Warrant.

Q

When is BioCardia, Inc. - Warrant (NASDAQ:BCDAW) reporting earnings?

A

BioCardia, Inc. - Warrant does not have any upcoming earnings scheduled.

Q

Is BioCardia, Inc. - Warrant (BCDAW) going to split?

A

There is no upcoming split for BioCardia, Inc. - Warrant.

Q

What sector and industry does BioCardia, Inc. - Warrant (BCDAW) operate in?

A

BioCardia, Inc. - Warrant is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.